| Composite nanomaterials | Excitation/nm | Emission/nm | Applications | Ref |
|---|---|---|---|---|
| CdS/SrAl2O4:Eu2+, Dy3+ PLNPs/MOFs | >420 254 | 510 535 | Degradation MO Degradation RhB | |
| g-C3N4-Au@SrAl2O4:Eu2+, Dy3+ Sr2MgSi2O7:(Eu,Dy)/CdS PEI-PLNPs/Ab-AuNPs ZnGa2O4:Cr@MPA@Au PLNPs-CPBA-gel | >420 365 254 254 410 | 510 470 ~510 695 698 | Hydrogen evolution Hydrogen evolution Detection of tumor markers Detection of tumor markers Detection of tumor markers | |
| Apt-PLNPs@cDNA-Fe3O4 | 254 | 537, 701 | Detection of ZEN and AFB1 | |
| ZGC/HZIF-8 | 254 | 700 | Detection of dopamine | |
| PLNPs@UCNPs PLNPs@SiO2@MnO2 Gd(III)-PLNPs | 980 254 254 254 | 700 702 700 | Optical imaging Optical imaging Dual-modal imaging | |
| PLNPs-Gd2O3-HA ZGGO@TaOx@SiO2 Gd2O3@mSiO2@CaTiO3:Pr3+ Gd2O3@mSiO2/ZnGa2O4:Cr3+, Bi3+ | 254 270 327 254 | 700 695 613 695 | Dual-modal bioimaging Dual-modal bioimaging Dual-modal bioimaging Dual-modal bioimaging | |
| Mn-ZGOCS-PEG GdAlO3:Mn4+, Ge4+@Au PLNPs@ZIF-8 PLNPs@MIL-100(Fe) PLNP@UIO-66 PLNP@GNR | 254 254 254 254 254 635 | 695 690, 713 699, 696 700 697 697 | Dual-modal bioimaging Tri-modal bioimaging Drug delivery Bioimaging Drug delivery Bioimaging Drug delivery Biomaging Photothermal therapy | |
| PLNP-Bi2S3 | 635 | 697 | Photothermal therapy | |
| NaYF4:Yb,Tm@SrAl2O4:Eu,Dy S-PLNP@MnO2-PSMD | 980 273 | ~510 697 | Photodynamic therapy Photodynamic therapy | |
| Zn1.05Ga1.9O4:Cr@SiO2@MOF | 254 | 696 | Combination therapy | |
| LiLuGeO4:Bi3+/TiO2 | 254 | ~385 | Treatment of bacterial infections | |
| CsPbBr3/SMS@SiO2 CsPbI3-CsPbBr3/SMS@SiO2 CDs/CAO NaYF4:Yb,Tm/ ZGO:Mn,Li Sr2ZnSi2O7:Eu2+, Dy3+/PAN | 365 365 310 365 360 | 465, 525 460, 680 ~650 540 470 | Anti-counterfeiting Anti-counterfeiting Anti-counterfeiting Anti-counterfeiting Anti-counterfeiting |
